ADAR1 Capital Management
Latest statistics and disclosures from ADAR1 Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ABVX, PTGX, SPY, ROIV, IMVT, and represent 31.15% of ADAR1 Capital Management's stock portfolio.
- Added to shares of these 10 stocks: SPY (+$58M), ABVX (+$55M), AGIO (+$43M), ZLAB (+$37M), EDIT (+$29M), PRAX (+$24M), INSM (+$21M), ENTA (+$19M), RLYB (+$15M), VKTX (+$14M).
- Started 44 new stock positions in SGMT, COGT, BOLD, APGE, Jatt Ii Acquisition Corp, Disciplined Growth, RNTX, CLNN, CCXI, STIP.
- Reduced shares in these 10 stocks: TERN (-$59M), BEAM (-$35M), DNLI (-$22M), SRRK (-$20M), CYTK (-$15M), IMVT (-$13M), MPLT (-$13M), REPL (-$11M), SNY (-$11M), ABUS (-$9.0M).
- Sold out of its positions in ACRS, ACET, JBIO, FOLD, ANNX, Apellis Pharmaceuticals, AQST, ACLX, ARCT, AVBP.
- ADAR1 Capital Management was a net buyer of stock by $209M.
- ADAR1 Capital Management has $2.2B in assets under management (AUM), dropping by 28.64%.
- Central Index Key (CIK): 0001940272
Tip: Access up to 7 years of quarterly data
Positions held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for ADAR1 Capital Management
ADAR1 Capital Management holds 272 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Abivax Sa Sponsored Ads (ABVX) | 11.3 | $246M | +28% | 1.8M | 133.26 |
|
| Protagonist Therapeutics (PTGX) | 5.4 | $118M | -3% | 961k | 122.58 |
|
| State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY) | 5.3 | $115M | +102% | 154k | 746.77 |
|
| Roivant Sciences SHS (ROIV) | 5.1 | $112M | -3% | 3.2M | 35.39 |
|
| Immunovant (IMVT) | 4.1 | $90M | -13% | 2.3M | 38.53 |
|
| Zai Lab Adr (ZLAB) | 2.9 | $64M | +136% | 3.4M | 19.00 |
|
| Agios Pharmaceuticals (AGIO) | 2.2 | $48M | +815% | 1.3M | 37.11 |
|
| Crinetics Pharmaceuticals In (CRNX) | 2.1 | $46M | +7% | 1.2M | 37.42 |
|
| Ea Series Trust Alpha Arch 1-3 (BOXX) | 1.8 | $40M | 337k | 117.09 |
|
|
| Cytokinetics Com New (CYTK) | 1.8 | $39M | -27% | 458k | 85.19 |
|
| Septerna (SEPN) | 1.4 | $32M | -13% | 941k | 33.49 |
|
| Anteris Technologies Global (AVR) | 1.4 | $31M | -16% | 3.1M | 9.85 |
|
| Editas Medicine (EDIT) | 1.3 | $29M | NEW | 8.9M | 3.24 |
|
| Denali Therapeutics (DNLI) | 1.2 | $27M | -45% | 1.0M | 25.72 |
|
| Spyre Therapeutics Com New (SYRE) | 1.2 | $25M | -16% | 284k | 88.78 |
|
| Vir Biotechnology (VIR) | 1.1 | $25M | -10% | 2.5M | 10.19 |
|
| Praxis Precision Medicines I Com New (PRAX) | 1.1 | $25M | +4850% | 74k | 334.79 |
|
| Insmed Com Par $.01 (INSM) | 1.1 | $24M | +545% | 229k | 106.62 |
|
| Celldex Therapeutics Com New (CLDX) | 1.1 | $23M | +44% | 620k | 37.21 |
|
| Viking Therapeutics (VKTX) | 1.0 | $22M | +152% | 574k | 39.01 |
|
| Taysha Gene Therapies Com Shs (TSHA) | 0.9 | $21M | +2% | 3.0M | 6.81 |
|
| Monopar Therapeutics Com New (MNPR) | 0.9 | $20M | -17% | 218k | 92.59 |
|
| Ovid Therapeutics (OVID) | 0.9 | $20M | +63% | 7.4M | 2.69 |
|
| Enliven Therapeutics (ELVN) | 0.9 | $20M | +17% | 388k | 50.75 |
|
| Enanta Pharmaceuticals (ENTA) | 0.9 | $20M | +2517% | 1.3M | 14.58 |
|
| Ishares Tr Russell 2000 Etf Put Option (IWM) | 0.9 | $19M | +127% | 63k | 300.45 |
|
| Nektar Therapeutics Com New (NKTR) | 0.8 | $17M | +51% | 244k | 69.81 |
|
| Inspire Med Sys (INSP) | 0.8 | $17M | -7% | 375k | 44.61 |
|
| Revolution Medicines (RVMD) | 0.7 | $16M | -34% | 88k | 187.28 |
|
| Establishment Labs Holdings Ord (ESTA) | 0.7 | $16M | -13% | 186k | 85.81 |
|
| Prothena Corp SHS (PRTA) | 0.7 | $15M | 1.6M | 9.79 |
|
|
| Rhythm Pharmaceuticals (RYTM) | 0.7 | $15M | -35% | 136k | 111.03 |
|
| Inhibikase Therapeutics Com New (IKT) | 0.7 | $15M | +11% | 7.4M | 2.03 |
|
| Uniqure Nv SHS (QURE) | 0.7 | $15M | +84% | 325k | 46.06 |
|
| Rallybio Corp (RLYB) | 0.7 | $15M | +4411% | 926k | 16.00 |
|
| Regeneron Pharmaceuticals (REGN) | 0.6 | $14M | +82% | 22k | 623.54 |
|
| Inventiva Sa Ads (IVA) | 0.6 | $14M | +65% | 3.6M | 3.78 |
|
| Sutro Biopharma Com Shs (STRO) | 0.6 | $13M | -22% | 404k | 33.20 |
|
| Ionis Pharmaceuticals (IONS) | 0.6 | $13M | +3% | 166k | 79.29 |
|
| Bridgebio Pharma (BBIO) | 0.6 | $13M | +87% | 177k | 74.48 |
|
| Sarepta Therapeutics (SRPT) | 0.6 | $13M | +178% | 731k | 17.97 |
|
| Cytomx Therapeutics (CTMX) | 0.6 | $13M | 3.4M | 3.75 |
|
|
| Vor Biopharma Com New (VOR) | 0.6 | $13M | NEW | 681k | 18.41 |
|
| Spdr Series Trust St Str Blo 1 Etf (BIL) | 0.6 | $12M | 136k | 91.64 |
|
|
| Equillium (EQ) | 0.6 | $12M | 3.8M | 3.20 |
|
|
| Adlai Nortye Sponsored Ads (ANL) | 0.5 | $12M | +763% | 1.0M | 11.50 |
|
| Eliem Therapeutics (CLYM) | 0.5 | $11M | +37% | 823k | 13.04 |
|
| Spdr Series Trust St Str Sp Biot Put Option (XBI) | 0.5 | $11M | +349% | 67k | 158.25 |
|
| Helix Acquisition Corp Iii Usd Cl A Ord Shs (HLXC) | 0.5 | $11M | 1.0M | 10.60 |
|
|
| Zura Bio Class A Ord Shs (ZURA) | 0.5 | $10M | +179% | 1.8M | 5.90 |
|
| Onkure Therapeutics Com Cl A (OKUR) | 0.5 | $10M | -8% | 2.2M | 4.56 |
|
| Maze Therapeatics (MAZE) | 0.5 | $10M | +577% | 339k | 29.84 |
|
| Xenon Pharmaceuticals (XENE) | 0.5 | $10M | -27% | 167k | 60.36 |
|
| Amylyx Pharmaceuticals Put Option (AMLX) | 0.4 | $9.6M | -46% | 535k | 17.96 |
|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 0.4 | $9.4M | +3% | 278k | 33.88 |
|
| Urogen Pharma (URGN) | 0.4 | $9.3M | -36% | 252k | 36.80 |
|
| Faeth Therapeutics Com New (FTH) | 0.4 | $9.0M | NEW | 361k | 25.00 |
|
| Dbv Technologies S A Sponsored Ads (DBVT) | 0.4 | $8.7M | -47% | 528k | 16.40 |
|
| Savara (SVRA) | 0.4 | $8.6M | -4% | 1.4M | 6.16 |
|
| Vaxcyte (PCVX) | 0.4 | $8.5M | -43% | 146k | 58.13 |
|
| Cg Oncology (CGON) | 0.4 | $8.4M | -36% | 119k | 71.05 |
|
| Mineralys Therapeutics (MLYS) | 0.4 | $8.1M | +93% | 299k | 26.98 |
|
| Ascendis Pharma A/s Ord Shs (ASND) | 0.3 | $7.6M | NEW | 29k | 266.72 |
|
| Amanat Acquisition Corp Cl A Ord | 0.3 | $7.6M | NEW | 750k | 10.16 |
|
| Nurix Therapeutics (NRIX) | 0.3 | $7.6M | +458% | 313k | 24.26 |
|
| Biohaven (BHVN) | 0.3 | $7.5M | +1020% | 502k | 14.88 |
|
| Prime Medicine (PRME) | 0.3 | $7.4M | 2.0M | 3.69 |
|
|
| Perceptive Cap Solutions Cor Cl A Ord Shs (PCSC) | 0.3 | $7.3M | +35% | 675k | 10.88 |
|
| Ocuphire Pharma (IRD) | 0.3 | $7.3M | -3% | 1.8M | 4.11 |
|
| Lexeo Therapeutics (LXEO) | 0.3 | $7.3M | +6% | 1.6M | 4.66 |
|
| Damora Therapeutics Com New (DMRA) | 0.3 | $7.3M | 280k | 26.01 |
|
|
| Replimune Group (REPL) | 0.3 | $7.3M | -61% | 656k | 11.07 |
|
| Athira Pharma (LONA) | 0.3 | $7.1M | +6% | 777k | 9.19 |
|
| Korro Bio (KRRO) | 0.3 | $7.1M | 540k | 13.18 |
|
|
| Research Alliance Corp Iii Ord Shs Cl A | 0.3 | $7.0M | NEW | 650k | 10.70 |
|
| Inflarx Nv (IFRX) | 0.3 | $6.7M | +1795% | 3.0M | 2.24 |
|
| Relay Therapeutics (RLAY) | 0.3 | $6.7M | NEW | 358k | 18.71 |
|
| Janux Therapeutics (JANX) | 0.3 | $6.5M | +40% | 421k | 15.36 |
|
| Pliant Therapeutics (PLRX) | 0.3 | $6.3M | +113% | 5.5M | 1.14 |
|
| Aadi Bioscience (WHWK) | 0.3 | $6.1M | +943% | 1.3M | 4.58 |
|
| Krystal Biotech (KRYS) | 0.3 | $6.1M | -17% | 16k | 371.67 |
|
| Arbutus Biopharma (ABUS) | 0.3 | $6.1M | -59% | 1.3M | 4.80 |
|
| Pfizer (PFE) | 0.3 | $6.1M | +226% | 252k | 24.08 |
|
| Brighthouse Finl (BHF) | 0.3 | $6.0M | 96k | 63.30 |
|
|
| Edgewise Therapeutics (EWTX) | 0.3 | $5.8M | +58% | 143k | 40.63 |
|
| Alector (ALEC) | 0.3 | $5.8M | +174% | 2.9M | 2.01 |
|
| Fulcrum Therapeutics (FULC) | 0.3 | $5.7M | +1098% | 1.6M | 3.66 |
|
| Arrowhead Pharmaceuticals (ARWR) | 0.3 | $5.7M | 70k | 81.51 |
|
|
| Acumen Pharmaceuticals (ABOS) | 0.3 | $5.6M | -2% | 2.1M | 2.67 |
|
| Oaktree Acquisition Corp Iii Unit 10/04/2029 (OACCU) | 0.3 | $5.6M | 517k | 10.84 |
|
|
| Globus Med Cl A (GMED) | 0.3 | $5.5M | +248% | 70k | 79.01 |
|
| Monte Rosa Therapeutics (GLUE) | 0.2 | $5.2M | 217k | 24.20 |
|
|
| Disciplined Growth Unit 99/99/9999 | 0.2 | $5.0M | NEW | 500k | 10.04 |
|
| Bhav Acquisition Corp Unit 03/18/2031 (BHAVU) | 0.2 | $5.0M | 495k | 10.11 |
|
|
| Bridgebio Pharma Note 1.750% 3/0 (Principal) | 0.2 | $5.0M | 30k | 166.64 |
|
|
| Bridgebio Pharma Note 2.250% 2/0 (Principal) | 0.2 | $4.9M | 45k | 109.81 |
|
|
| Danaher Corporation (DHR) | 0.2 | $4.9M | -16% | 26k | 190.48 |
|
| Boundless Bio (BOLD) | 0.2 | $4.9M | NEW | 2.0M | 2.50 |
|
| Avalyn Pharmaceuticals Com Shs | 0.2 | $4.8M | NEW | 146k | 32.92 |
|
| Silverback Therapeutics (SPRY) | 0.2 | $4.8M | -55% | 601k | 8.01 |
|
| Ataibeckley Com Shs (ATAI) | 0.2 | $4.8M | 913k | 5.27 |
|
|
| Prelude Therapeutics (PRLD) | 0.2 | $4.8M | +489% | 901k | 5.33 |
|
| Jatt Ii Acquisition Corp Ord Shs | 0.2 | $4.7M | NEW | 418k | 11.36 |
|
| Rein Therapeutics Com New (RNTX) | 0.2 | $4.7M | NEW | 4.5M | 1.04 |
|
| Pepgen (PEPG) | 0.2 | $4.7M | +61% | 2.6M | 1.80 |
|
| Contineum Therapeutics Cl A (CTNM) | 0.2 | $4.6M | 279k | 16.39 |
|
|
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 0.2 | $4.5M | +31% | 482k | 9.38 |
|
| Perspective Therapeutics Com New (CATX) | 0.2 | $4.1M | +61% | 1.2M | 3.41 |
|
| Apogee Therapeutics (APGE) | 0.2 | $4.1M | NEW | 31k | 132.73 |
|
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.2 | $4.0M | 119k | 33.89 |
|
|
| Biogen Idec (BIIB) | 0.2 | $3.9M | +62% | 18k | 216.06 |
|
| Xencor (XNCR) | 0.2 | $3.7M | +148% | 233k | 16.10 |
|
| Silence Therapeutics Ads (SLN) | 0.2 | $3.7M | +96% | 338k | 10.98 |
|
| Spruce Biosciences Com New (SPRB) | 0.2 | $3.7M | +15% | 68k | 54.00 |
|
| Pharvaris N V (PHVS) | 0.2 | $3.6M | 106k | 34.58 |
|
|
| Engene Therapeutics (ENGN) | 0.2 | $3.6M | NEW | 2.1M | 1.73 |
|
| Palisade Bio (PALI) | 0.2 | $3.6M | -23% | 1.7M | 2.09 |
|
| Protara Therapeutics Com Stk (TARA) | 0.2 | $3.6M | 941k | 3.82 |
|
|
| Bridgebio Pharma Note 2.500% 3/1 (Principal) | 0.2 | $3.5M | 20k | 173.09 |
|
|
| Sagimet Biosciences Com Ser A (SGMT) | 0.2 | $3.4M | NEW | 438k | 7.73 |
|
| Beone Medicines Sponsored Ads (ONC) | 0.2 | $3.3M | 12k | 284.97 |
|
|
| Adagio Therapeutics (IVVD) | 0.2 | $3.3M | 3.8M | 0.87 |
|
|
| Tenax Therapeutics Com New (TENX) | 0.1 | $3.2M | +3% | 221k | 14.55 |
|
| Zentalis Pharmaceuticals (ZNTL) | 0.1 | $3.2M | +351% | 653k | 4.85 |
|
| Relmada Therapeutics (RLMD) | 0.1 | $3.1M | 452k | 6.92 |
|
|
| Delcath Sys Com New (DCTH) | 0.1 | $2.8M | 224k | 12.59 |
|
|
| BioMarin Pharmaceutical (BMRN) | 0.1 | $2.8M | +169% | 49k | 57.22 |
|
| Summit Therapeutics (SMMT) | 0.1 | $2.8M | +108% | 192k | 14.57 |
|
| Keros Therapeutics (KROS) | 0.1 | $2.6M | +153% | 247k | 10.70 |
|
| Eledon Pharmaceuticals (ELDN) | 0.1 | $2.6M | -33% | 648k | 3.94 |
|
| Sanofi Sa Sponsored Adr (SNY) | 0.1 | $2.4M | -81% | 57k | 42.66 |
|
| American Exceptionalism Acqu Ord Cl A (AEXA) | 0.1 | $2.4M | -42% | 205k | 11.82 |
|
| Tango Therapeutics (TNGX) | 0.1 | $2.4M | +53% | 77k | 31.26 |
|
| Intuitive Surgical Com New (ISRG) | 0.1 | $2.4M | +229% | 6.0k | 397.68 |
|
| Inovio Pharmaceuticals Com Shs (INO) | 0.1 | $2.4M | +45% | 2.1M | 1.10 |
|
| Omniab (OABI) | 0.1 | $2.3M | +34% | 947k | 2.46 |
|
| Capricor Therapeutics Com New (CAPR) | 0.1 | $2.2M | 91k | 24.08 |
|
|
| Bright Minds Biosciences Com New (DRUG) | 0.1 | $2.1M | -10% | 30k | 70.20 |
|
| Oruka Therapeutics (ORKA) | 0.1 | $2.0M | 21k | 95.17 |
|
|
| Vyne Therapeutics (VYNE) | 0.1 | $1.9M | +177% | 3.0M | 0.65 |
|
| Novo-nordisk A S Adr (NVO) | 0.1 | $1.9M | -13% | 40k | 47.94 |
|
| McKesson Corporation (MCK) | 0.1 | $1.9M | +108% | 2.5k | 755.60 |
|
| Lexicon Pharmaceuticals Com New (LXRX) | 0.1 | $1.8M | 750k | 2.40 |
|
|
| Corvus Pharmaceuticals (CRVS) | 0.1 | $1.7M | +33% | 117k | 14.94 |
|
| Cue Biopharma (CUE) | 0.1 | $1.7M | NEW | 55k | 31.56 |
|
| Satellos Bioscience (MSLE) | 0.1 | $1.7M | 223k | 7.78 |
|
|
| Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) | 0.1 | $1.7M | 27k | 63.95 |
|
|
| Connect Biopharma Hldgs SHS (CNTB) | 0.1 | $1.7M | -5% | 700k | 2.38 |
|
| Cohen Circle Acquisit Corp I Unit 07/01/2030 (CCIIU) | 0.1 | $1.6M | 150k | 10.51 |
|
|
| Rocket Pharmaceuticals (RCKT) | 0.1 | $1.5M | 436k | 3.42 |
|
|
| First Tracks Biotherapeutics Ord Shs (TRAX) | 0.1 | $1.4M | NEW | 72k | 20.12 |
|
| Evommune Com Shs (EVMN) | 0.1 | $1.4M | -43% | 104k | 13.29 |
|
| C4 Therapeutics Com Stk (CCCC) | 0.1 | $1.4M | +578% | 292k | 4.67 |
|
| BioCryst Pharmaceuticals (BCRX) | 0.1 | $1.3M | +26% | 133k | 10.00 |
|
| Supernus Pharmaceuticals (SUPN) | 0.1 | $1.3M | -6% | 28k | 46.51 |
|
| Avantor (AVTR) | 0.1 | $1.3M | +62% | 130k | 9.90 |
|
| Inmed Pharmaceuticals Com New (INM) | 0.1 | $1.2M | NEW | 800k | 1.55 |
|
| Promis Neurosciences Com Shs (PMN) | 0.1 | $1.2M | -2% | 93k | 13.16 |
|
| Arrowhead Pharmaceuticals In Note 1/1 (Principal) | 0.1 | $1.2M | 10k | 119.06 |
|
|
| Artiva Biotherapeutics (ARTV) | 0.1 | $1.2M | NEW | 119k | 9.70 |
|
| Tenaya Therapeutics (TNYA) | 0.1 | $1.1M | +3% | 1.6M | 0.74 |
|
| Alx Oncology Hldgs (ALXO) | 0.1 | $1.1M | NEW | 534k | 2.07 |
|
| Alexandria Real Estate Equities (ARE) | 0.0 | $1.0M | 20k | 52.85 |
|
|
| Cartesian Therapeutics Com New (RNAC) | 0.0 | $1.0M | NEW | 99k | 10.42 |
|
| Cyclerion Therapeutics (CYCN) | 0.0 | $1.0M | NEW | 299k | 3.39 |
|
| Electronic Arts (EA) | 0.0 | $1.0M | 4.9k | 205.04 |
|
|
| Travere Therapeutics Note 0.500% 5/1 (Principal) | 0.0 | $1.0M | NEW | 10k | 100.00 |
|
| Biontech Se Sponsored Ads (BNTX) | 0.0 | $986k | +6% | 11k | 93.05 |
|
| ACADIA Pharmaceuticals (ACAD) | 0.0 | $986k | NEW | 39k | 25.30 |
|
| Dyne Therapeutics (DYN) | 0.0 | $951k | -9% | 43k | 22.21 |
|
| Maplight Therapeutics (MPLT) | 0.0 | $950k | -92% | 27k | 35.84 |
|
| Structure Therapeutics Sponsored Ads (GPCR) | 0.0 | $939k | NEW | 18k | 53.67 |
|
| Keen Vision Acquisition Corp SHS Call Option (KVAC) | 0.0 | $930k | 75k | 12.40 |
|
|
| Wave Life Sciences SHS (WVE) | 0.0 | $930k | +256% | 160k | 5.81 |
|
| Aura Biosciences (AURA) | 0.0 | $924k | NEW | 130k | 7.10 |
|
| Churchill Cap Corp Xi Cl A Ord Shs (CCXI) | 0.0 | $873k | NEW | 50k | 17.45 |
|
| Kazia Therapeutics Sponsored Ads (KZIA) | 0.0 | $867k | NEW | 62k | 14.08 |
|
| Nuvalent Inc-a (NUVL) | 0.0 | $857k | 6.9k | 123.50 |
|
|
| Larimar Therapeutics (LRMR) | 0.0 | $832k | +417% | 273k | 3.05 |
|
| Vera Therapeutics Cl A (VERA) | 0.0 | $786k | +14% | 18k | 42.91 |
|
| Adagio Med Hldgs (ADGM) | 0.0 | $786k | 1.2M | 0.65 |
|
|
| Atrium Therapeutics (RNA) | 0.0 | $776k | 58k | 13.45 |
|
|
| Therapeuticsmd Com New (TXMD) | 0.0 | $757k | +63% | 342k | 2.21 |
|
| Ideaya Biosciences (IDYA) | 0.0 | $745k | 20k | 37.27 |
|
|
| Si-bone (SIBN) | 0.0 | $734k | +257% | 45k | 16.32 |
|
| Royalty Pharma Shs Class A (RPRX) | 0.0 | $701k | +150% | 13k | 56.07 |
|
| Evolus (EOLS) | 0.0 | $694k | +79% | 100k | 6.94 |
|
| Ultragenyx Pharmaceutical Call Option (RARE) | 0.0 | $668k | -40% | 20k | 33.39 |
|
| Ibio Com New (IBIO) | 0.0 | $657k | -20% | 376k | 1.75 |
|
| Forward Air Corp (FWRD) | 0.0 | $652k | -38% | 48k | 13.51 |
|
| Geron Corporation (GERN) | 0.0 | $647k | +152% | 506k | 1.28 |
|
| Stryker Corporation (SYK) | 0.0 | $630k | NEW | 2.0k | 314.84 |
|
| Iovance Biotherapeutics (IOVA) | 0.0 | $608k | NEW | 146k | 4.16 |
|
| Macrogenics (MGNX) | 0.0 | $600k | +224% | 130k | 4.62 |
|
| Gilead Sciences (GILD) | 0.0 | $587k | -26% | 4.6k | 126.34 |
|
| Natera (NTRA) | 0.0 | $583k | 2.1k | 271.45 |
|
|
| Seaport Therapeutics Common Stock | 0.0 | $565k | NEW | 26k | 21.72 |
|
| Assembly Biosciences Com New (ASMB) | 0.0 | $562k | +2% | 20k | 27.48 |
|
| Cybin Com New (HELP) | 0.0 | $537k | +159% | 81k | 6.61 |
|
| Benitec Biopharma Com New (BNTC) | 0.0 | $535k | +128% | 40k | 13.38 |
|
| Polypid (PYPD) | 0.0 | $528k | 104k | 5.08 |
|
|
| Pulmonx Corp (LUNG) | 0.0 | $526k | +8% | 405k | 1.30 |
|
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.0 | $526k | -94% | 27k | 19.47 |
|
| Globa Terra Acquisition Cor Unit 99/99/9999 (GTERU) | 0.0 | $520k | 50k | 10.39 |
|
|
| Traws Pharma Com New (TRAW) | 0.0 | $504k | +287% | 598k | 0.84 |
|
| Wisdomtree Tr Floatng Rat Trea (USFR) | 0.0 | $504k | 10k | 50.35 |
|
|
| Tectonic Therapeutic (TECX) | 0.0 | $499k | +11% | 15k | 34.38 |
|
| Madrigal Pharmaceuticals (MDGL) | 0.0 | $481k | 895.00 | 536.95 |
|
|
| Arvinas Ord (ARVN) | 0.0 | $479k | 58k | 8.31 |
|
|
| Orthopediatrics Corp. (KIDS) | 0.0 | $478k | +25% | 25k | 19.13 |
|
| Cogent Biosciences (COGT) | 0.0 | $472k | NEW | 12k | 38.70 |
|
| Phathom Pharmaceuticals (PHAT) | 0.0 | $466k | 43k | 10.85 |
|
|
| Mirum Pharmaceuticals (MIRM) | 0.0 | $457k | -37% | 3.9k | 117.07 |
|
| Kiora Pharmaceuticals (KPRX) | 0.0 | $442k | 168k | 2.63 |
|
|
| Kura Oncology (KURA) | 0.0 | $439k | 40k | 10.97 |
|
|
| Context Therapeutics (CNTX) | 0.0 | $416k | +113% | 751k | 0.55 |
|
| Ishares Tr 0-5 Yr Tips Etf (STIP) | 0.0 | $409k | NEW | 4.0k | 102.16 |
|
| Kalaris Therapeutics (KLRS) | 0.0 | $407k | 100k | 4.07 |
|
|
| Bicara Therapeutics (BCAX) | 0.0 | $407k | 14k | 29.69 |
|
|
| Merck & Co (MRK) | 0.0 | $404k | 3.1k | 128.50 |
|
|
| Neumora Therapeutics (NMRA) | 0.0 | $357k | +534% | 210k | 1.70 |
|
| Irhythm Technologies (IRTC) | 0.0 | $357k | NEW | 3.0k | 118.95 |
|
| Achieve Life Sciences (ACHV) | 0.0 | $351k | +12% | 54k | 6.53 |
|
| Alibaba Group Hldg Sponsored Ads (BABA) | 0.0 | $343k | 3.6k | 95.98 |
|
|
| Ww Intl Com New (WW) | 0.0 | $340k | -63% | 21k | 15.98 |
|
| CNS Pharmaceuticals (CNSP) | 0.0 | $335k | NEW | 70k | 4.78 |
|
| Crescent Biopharma (CBIO) | 0.0 | $329k | -63% | 18k | 18.00 |
|
| Boston Scientific Corporation (BSX) | 0.0 | $320k | -25% | 7.5k | 42.68 |
|
| Altimmune Com New (ALT) | 0.0 | $313k | NEW | 103k | 3.04 |
|
| Verastem Com New (VSTM) | 0.0 | $290k | +6% | 76k | 3.82 |
|
| An2 Therapeutics (ANTX) | 0.0 | $285k | +324% | 59k | 4.84 |
|
| Journey Med Corp (DERM) | 0.0 | $280k | NEW | 40k | 7.08 |
|
| Procap Acquisition Corp Unit 05/16/2030 (PCAPU) | 0.0 | $279k | 27k | 10.37 |
|
|
| Pmv Pharmaceuticals (PMVP) | 0.0 | $269k | -12% | 201k | 1.34 |
|
| Compass Therapeutics (CMPX) | 0.0 | $268k | -12% | 122k | 2.19 |
|
| Jd.com Spon Ads Cl A (JD) | 0.0 | $255k | 10k | 25.48 |
|
|
| Rezolute Com New (RZLT) | 0.0 | $253k | -17% | 49k | 5.20 |
|
| Anaptysbio Inc Common (ANAB) | 0.0 | $250k | 3.7k | 67.50 |
|
|
| Neurogene (NGNE) | 0.0 | $245k | NEW | 7.8k | 31.45 |
|
| Ishares Tr U.s. Med Dvc Etf (IHI) | 0.0 | $242k | NEW | 4.9k | 49.41 |
|
| Rxsight (RXST) | 0.0 | $241k | +15% | 50k | 4.82 |
|
| Coya Therapeutics Common Stock (COYA) | 0.0 | $239k | 41k | 5.85 |
|
|
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.0 | $215k | -28% | 51k | 4.24 |
|
| Cantor Equity Partners Vi In Cl A Ord Shs (CEPS) | 0.0 | $207k | 20k | 10.37 |
|
|
| Scynexis | 0.0 | $201k | NEW | 49k | 4.07 |
|
| Personalis Ord (PSNL) | 0.0 | $201k | -40% | 15k | 13.40 |
|
| Q/c Technologies (QCLS) | 0.0 | $195k | 50k | 3.90 |
|
|
| Cabaletta Bio (CABA) | 0.0 | $156k | NEW | 50k | 3.11 |
|
| Recursion Pharmaceuticals In Cl A (RXRX) | 0.0 | $151k | +17% | 41k | 3.67 |
|
| Organon & Co Common Stock (OGN) | 0.0 | $135k | 10k | 13.54 |
|
|
| Milestone Pharmaceuticals (MIST) | 0.0 | $134k | 100k | 1.34 |
|
|
| Neuphoria Therapeutics (NEUP) | 0.0 | $131k | 30k | 4.37 |
|
|
| Neuronetics (STIM) | 0.0 | $130k | 100k | 1.30 |
|
|
| Chemomab Therapeutics Sponsored Ads (CMMB) | 0.0 | $130k | 80k | 1.62 |
|
|
| Solidion Technology Com New Call Option (STI) | 0.0 | $125k | 14k | 9.29 |
|
|
| Voyager Therapeutics (VYGR) | 0.0 | $123k | 35k | 3.50 |
|
|
| Entrada Therapeutics (TRDA) | 0.0 | $114k | -49% | 16k | 7.36 |
|
| Veru Com New (VERU) | 0.0 | $110k | 35k | 3.13 |
|
|
| Cantor Equity Partners Vii I Cl A Ord Shs | 0.0 | $101k | NEW | 10k | 10.09 |
|
| Clene Com New (CLNN) | 0.0 | $92k | NEW | 15k | 6.16 |
|
| Vistagen Therapeutics Ord (VTGN) | 0.0 | $79k | -53% | 351k | 0.23 |
|
| Longeveron Cl A New (LGVN) | 0.0 | $76k | -45% | 108k | 0.70 |
|
| Biomea Fusion (BMEA) | 0.0 | $64k | 43k | 1.47 |
|
|
| Mei Pharma (LITS) | 0.0 | $62k | 67k | 0.92 |
|
|
| Jasper Therapeutics Com New (JSPR) | 0.0 | $59k | 140k | 0.42 |
|
|
| Ardelyx (ARDX) | 0.0 | $56k | -53% | 11k | 5.10 |
|
| Gossamer Bio (GOSS) | 0.0 | $35k | -26% | 213k | 0.16 |
|
| Atyr Pharma Com New (ATYR) | 0.0 | $30k | 51k | 0.60 |
|
|
| A Spac Iii Acquisition Corp Right 01/02/2026 (ASPCR) | 0.0 | $19k | 215k | 0.09 |
|
|
| Proqr Thrapeutics N V Shs Euro (PRQR) | 0.0 | $19k | 10k | 1.86 |
|
|
| Best Spac I Acquisition Corp Right 05/27/2030 (BSAAR) | 0.0 | $17k | NEW | 100k | 0.17 |
|
| Coherus Biosciences (CHRS) | 0.0 | $15k | 10k | 1.40 |
|
Past Filings by ADAR1 Capital Management
SEC 13F filings are viewable for ADAR1 Capital Management going back to 2023
- ADAR1 Capital Management 2026 Q2 filed Aug. 14, 2026
- ADAR1 Capital Management 2026 Q1 filed May 18, 2026
- ADAR1 Capital Management 2025 Q4 restated filed Feb. 18, 2026
- ADAR1 Capital Management 2025 Q4 filed Feb. 17, 2026
- ADAR1 Capital Management 2025 Q3 filed Nov. 14, 2025
- ADAR1 Capital Management 2025 Q2 filed Aug. 14, 2025
- ADAR1 Capital Management 2025 Q1 filed May 15, 2025
- ADAR1 Capital Management 2024 Q4 filed Feb. 13, 2025
- ADAR1 Capital Management 2024 Q3 filed Nov. 14, 2024
- ADAR1 Capital Management 2024 Q2 filed Aug. 13, 2024
- ADAR1 Capital Management 2024 Q1 filed May 15, 2024
- ADAR1 Capital Management 2023 Q4 filed Feb. 14, 2024